Table Of Contents

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	31
2.4 Emerging Opportunities and Market Trends	34
2.5 Porter’s Fiver Forces Analysis	38
3 Segmentation of North America Market by Product	43
3.1 Market Overview by Product	43
3.2 Kits & Assays	45
3.3 Analyzers & Instruments	46
3.4 Software & Services	47
4 Segmentation of North America Market by Technology	48
4.1 Market Overview by Technology	48
4.2 Polymerase Chain Reaction (PCR)	50
4.2.1 Real-Time PCR (rt-PCR)	51
4.2.2 Digital PCR (d-PCR)	52
4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)	53
4.4 Genetic Sequencing-based Technology	54
4.5 Microarray-based Technology	55
4.6 Other Technologies	56
5 Segmentation of North America Market by Application	57
5.1 Market Overview by Application	57
5.2 Infectious Disease	59
5.2.1 Respiratory Infections	61
5.2.2 Hospital Acquired Infections	62
5.2.3 Sexually Transmitted Infections	63
5.3 Gastrointestinal Infections	64
5.4 Oncology	65
5.5 Hepatitis	66
5.6 Prenatal/Neonatal Testing	67
5.7 Other Applications	68
6 Segmentation of North America Market by End User	69
6.1 Market Overview by End User	69
6.2 Hospitals	71
6.3 Clinics & Diagnostic Centers	72
6.4 Research and Academic Institutes	73
6.5 Other End Users	74
7 North America Market 2019-2030 by Country	76
7.1 Overview of North America Market	76
7.2 U.S.	79
7.3 Canada	83
7.4 Mexico	85
8 Competitive Landscape	87
8.1 Overview of Key Vendors	87
8.2 New Product Launch, Partnership, Investment, and M&A	91
8.3 Company Profiles	92
Abacus Diagnostica Oy	92
Abbott Laboratories	94
Alere Inc.	95
Biocartis Group NV	96
Biomerieux SA	97
Bio-Rad Laboratories Inc	98
Danaher Corporation	99
DiaSorin S.p.A	100
DxNA LLC.	101
F. Hoffmann-La Roche Ltd.	102
Hologic, Inc.	103
Luminex Corporation	104
Meridian Bioscience Inc.	105
Mesa Biotech Inc.	106
QIAGEN N.V.	107
QuantuMDx Group Ltd.	108
Quidel Corporation	109
Spartan Biosciences Inc.	110
Thermo Fisher Scientific	111
9 Investing in North America Market: Risk Assessment and Management	112
9.1 Risk Evaluation of North America Market	112
9.2 Critical Success Factors (CSFs)	115
Related Reports and Products	118
?

List Of Tables

Table 1.  Snapshot of North America Point of Care (PoC) Molecular Diagnostics Market, 2019-2030	18
Table 2. Growth Rate of World Real GDP, 2017-2021	22
Table 3.  Main Product Trends and Market Opportunities in North America Point of Care (PoC) Molecular Diagnostics Market	34
Table 4. North America Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn	43
Table 5. North America Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn	48
Table 6. North America Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn	50
Table 7. North America Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn	57
Table 8. North America Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn	60
Table 9. North America Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn	69
Table 10. North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn	77
Table 11. U.S. Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn	81
Table 12. U.S. Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn	81
Table 13. U.S. Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn	81
Table 14. Canada Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn	84
Table 15. Canada Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn	84
Table 16. Canada Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn	84
Table 17. Mexico Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn	86
Table 18. Mexico Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn	86
Table 19. Mexico Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn	86
Table 20. Breakdown of North America Market by Key Vendor, 2019, %	89
Table 21. Abacus Diagnostica Oy: Company Snapshot	92
Table 22. Abacus Diagnostica Oy: Business Segmentation	92
Table 23. Abacus Diagnostica Oy: Product Portfolio	93
Table 24. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn	93
Table 25. Abacus Diagnostica Oy: Recent Developments	93
Table 26.  Risk Evaluation for Investing in North America Market, 2019-2030	113
Table 27. Critical Success Factors and Key Takeaways	116

List Of Figures

Figure 1. Research Method Flow Chart	11
Figure 2. Breakdown of Primary Research	13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	17
Figure 5. North America Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn	20
Figure 6. Impact of COVID-19 on Business	24
Figure 7. Primary Drivers and Impact Factors of North America Point of Care (PoC) Molecular Diagnostics Market	26
Figure 8. World Number of Deaths by Cause in 2017	29
Figure 9. World Number of Deaths from Cancers in 2017	30
Figure 10. Primary Restraints and Impact Factors of North America Point of Care (PoC) Molecular Diagnostics Market	31
Figure 11. Investment Opportunity Analysis	35
Figure 12. Porter’s Fiver Forces Analysis of North America Point of Care (PoC) Molecular Diagnostics Market	38
Figure 13. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue	43
Figure 14. North America Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)	44
Figure 15. North America Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn	45
Figure 16. North America Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn	46
Figure 17. North America Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn	47
Figure 18. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue	48
Figure 19. North America Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%)	49
Figure 20. North America Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn	50
Figure 21. North America Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn	51
Figure 22. North America Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn	52
Figure 23. North America Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn	53
Figure 24. North America Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn	54
Figure 25. North America Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn	55
Figure 26. North America Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn	56
Figure 27. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue	57
Figure 28. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)	58
Figure 29. North America Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn	59
Figure 30. North America Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn	61
Figure 31. North America Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn	62
Figure 32. North America Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn	63
Figure 33. North America Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn	64
Figure 34. North America Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn	65
Figure 35. North America Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn	66
Figure 36. North America Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn	67
Figure 37. North America Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn	68
Figure 38. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue	69
Figure 39. North America Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)	70
Figure 40. North America Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn	71
Figure 41. North America Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn	72
Figure 42. North America Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn	73
Figure 43. North America Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn	74
Figure 44. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue	77
Figure 45. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	78
Figure 46. U.S. Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn	80
Figure 47. Canada Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn	83
Figure 48.  Point of Care (PoC) Molecular Diagnostics Market in Mexico, 2015-2030, $ mn	85
Figure 49. Growth Stage of North America Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period	87

Key Players (this may not be a complete list and extra companies can be added upon request): 
Abacus Diagnostica Oy	
Abbott Laboratories	
Alere Inc.	
Biocartis Group NV	
Biomerieux SA	
Bio-Rad Laboratories Inc	
Danaher Corporation	
DiaSorin S.p.A	
DxNA LLC.	
F. Hoffmann-La Roche Ltd.	
Hologic, Inc.	
Luminex Corporation	
Meridian Bioscience Inc.	
Mesa Biotech Inc.	
QIAGEN N.V.	
QuantuMDx Group Ltd.	
Quidel Corporation	
Spartan Biosciences Inc.	
Thermo Fisher Scientific